Skip to main content

Advertisement

SpringerLink
Log in

F18-FDG-PET/CT thyroid incidentalomas and their benign or malignant nature: a critical and debated issue

  • Letter to the Editor
  • Published:
Annals of Nuclear Medicine Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Kim BH, Na MA, Kim IJ, Kim SJ, Kim YK. Risk stratification and prediction of cancer of focal thyroid fluorodeoxyglucose uptake during cancer evaluation. Ann Nucl Med. 2010. doi:10.1007/s12149-010-0414-6.

  2. Kumar R, Loving VA, Chauhan A, Zhuang H, Mitchell S, Alavi A. Potential of dual-time-point imaging to improve breast cancer diagnosis with (18)F-FDG PET. J Nucl Med. 2005;46:1819–24.

    PubMed  Google Scholar 

  3. D’Souza MM, Marwaha RK, Sharma R, Jaimini A, Thomas S, Singh D, et al. Prospective evaluation of solitary thyroid nodule on 18F-FDG PET/CT and high-resolution ultrasonography. Ann Nucl Med. 2010;24:345–55.

    Article  PubMed  Google Scholar 

  4. Suga K, Kawakami Y, Hiyama A, Sugi K, Okabe K, Matsumoto T, et al. Dual-time point 18F-FDG PET/CT scan for differentiation between 18F-FDG-avid non-small cell lung cancer and benign lesions. Ann Nucl Med. 2009;23:427–35.

    Article  PubMed  Google Scholar 

  5. Suga K, Kawakami Y, Hiyama A, Matsunaga N. Differentiation of FDG-avid loco-regional recurrent and compromised benign lesions after surgery for breast cancer with dual-time point F-18-fluorodeoxy-glucose PET/CT scan. Ann Nucl Med. 2009;23:399–407.

    Article  PubMed  Google Scholar 

  6. Suga K, Kawakami Y, Hiyama A, Sugi K, Okabe K, Matsumoto T, et al. Differential diagnosis between (18)F-FDG-avid metastatic lymph nodes in non-small cell lung cancer and benign nodes on dual-time point PET/CT scan. Ann Nucl Med. 2009;23:523–31.

    Article  PubMed  Google Scholar 

  7. Basu S, Zhuang H, Torigian DA, Rosenbaum J, Chen W, Alavi A. Functional imaging of inflammatory diseases using nuclear medicine techniques. Semin Nucl Med. 2009;39:124–45.

    Article  PubMed  Google Scholar 

  8. Basu S, Chryssikos T, Moghadam-Kia S, Zhuang H, Torigian DA, Alavi A. Positron emission tomography as a diagnostic tool in infection: present role and future possibilities. Semin Nucl Med. 2009;39:36–51.

    Article  PubMed  Google Scholar 

  9. Fletcher JW, Djulbegovic B, Soares HP, Siegel BA, Lowe VJ, Lyman GH, et al. Recommendations on the use of 18F-FDG PET in oncology. J Nucl Med. 2008;49:480–508.

    Article  PubMed  Google Scholar 

  10. Mian C, Barollo S, Pennelli G, Pavan N, Rugge M, Pelizzo MR, et al. Molecular characteristics in papillary thyroid cancers (PTCs) with no 131I uptake. Clin Endocrinol. 2008;68:108–16.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Nuclear Medicine, Spedali Civili di Brescia, P.le Spedali Civili, 1, 25123, Brescia, Italy

    Francesco Bertagna

  2. Department of Nuclear Medicine, University of Brescia, Brescia, Italy

    Raffaele Giubbini

Authors
  1. Francesco Bertagna
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Raffaele Giubbini
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Francesco Bertagna.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bertagna, F., Giubbini, R. F18-FDG-PET/CT thyroid incidentalomas and their benign or malignant nature: a critical and debated issue. Ann Nucl Med 25, 151–152 (2011). https://doi.org/10.1007/s12149-010-0443-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12149-010-0443-1

Keywords

Search

Navigation